SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is experiencing significant trading volume and upward momentum driven by its upcoming inclusion in the Russell 2000 and 3000 indexes. The community is actively debating the stock's valuation, institutional inflows, and the potential impact of its psychedelic pipeline on future acquisition or partnership opportunities within the pharmaceutical sector.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors digest a massive Q2 earnings beat and raised full-year profit outlook, fueled by AI-driven operational efficiencies and strong performance in their Optum segment. The community is actively debating the stock's momentum, with many highlighting the effective repricing strategy against medical cost pressures and speculating on further upside potential as the stock reclaims long-term technical levels.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is currently trending as investors scrutinize the company's significant increase in capital expenditure following strong quarterly earnings, triggering a sell-the-news reaction despite record-breaking AI-driven demand. The community is actively debating whether the CAPEX expansion is a justified long-term growth driver or a sign that the AI infrastructure bubble is facing a correction.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility and downward pressure as investors grapple with shifting semiconductor demand, mixed earnings sentiment, and geopolitical risks surrounding the Middle East. The community is sharply divided, with some betting on a recovery fueled by AI infrastructure needs while others fear a broader bubble correction amid concerns over overproduction and technical sell-offs.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors digest news of its aggressive expansion strategy, including plans for a multibillion-dollar manufacturing facility and continued efforts to scale its GLP-1 obesity pipeline globally. Community discussion is focused on the stock's long-term growth potential and its role as a stable defensive play amid broader rotation out of high-valuation technology names.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense volatility and a sharp pullback as investors rotate capital away from semiconductor memory stocks, fueled by fears that AI-related infrastructure spending may be overextended. While bears point to the stock's massive year-to-date gains and rising supply concerns as justification for the sell-off, bulls are actively debating whether this is a temporary sentiment reset or a structural breakdown in the AI narrative.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is facing significant volatility as investors weigh aggressive AI infrastructure growth expectations against broader semiconductor sector pullbacks. Community sentiment remains polarized between long-term bulls positioning for an AI-driven supercycle and vocal skeptics highlighting valuation concerns and recent price weakness.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is facing significant volatility as investors weigh a broader semiconductor pullback against the highly anticipated US debut of major holding SK Hynix. Community sentiment is deeply divided, with many traders viewing the recent price dips as a structural shakeout in the AI memory cycle, while others express frustration over the ETF's performance compared to its underlying components.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is seeing heavy volatility as investors weigh the stock's strong AI-driven memory demand against concerns regarding sector crowding and market-wide rotation. The community remains deeply divided between those viewing the pullback as a buying opportunity given the company's fundamentals and others fearing further downside amid aggressive short-term institutional trading.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors react to the company securing regulatory approval for Apple Intelligence in China and reports that it is actively pursuing semiconductor acquisitions to bolster its in-house AI infrastructure. The community remains divided between bullish sentiment regarding the potential for renewed upgrade cycles and strong ecosystem dominance versus bearish concerns over the stock's valuation relative to its growth rate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Telix Pharmaceuticals Limited (NASDAQ:TLX) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine research firms that are presently covering the stock...

Telix Pharmaceuticals Webinar Highlights Next-Gen PSMA Therapy, OPTIMAL-PSMA Enrollment Nears End

Telix Pharmaceuticals (NASDAQ:TLX) hosted an educational webinar outlining its next-generation prostate-specific membrane antigen (PSMA) radiopharmaceutical strategy, with management and a clinical...

Regeneron Boosts Cancer Pipeline Through Telix Collaboration

Regeneron teams up with Telix in a 50/50 radiopharma deal, betting on next-gen cancer therapies to expand its oncology pipeline and long-term growth.

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - What's Next?

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - Time to Sell...

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Should You Buy?

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's Why...

Wedbush Reaffirms Outperform Rating for Telix Pharmaceuticals (NASDAQ:TLX)

Wedbush reissued an "outperform" rating and set a $22.00 price target on shares of Telix Pharmaceuticals in a report on Monday...

Telix Pharmaceuticals (NASDAQ:TLX) Given "Buy" Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Telix Pharmaceuticals in a research report on Monday...

Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Telix Pharmaceuticals Ltd. (TLX, TLX.AX) announced Monday a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies...

Telix And Regeneron Partner To Advance Next-Generation Radiopharmaceutical Therapies

(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) and Regeneron Pharmaceuticals, Inc. (REGN) have announced a collaboration to jointly develop and commercialize next-generation...

Telix Pharmaceuticals (NASDAQ:TLX) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Telix Pharmaceuticals Ltd. - ADR

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

Equity

Bearish Sentiment

$100+

$80 - $99.99

$70 - $79.99

$60 - $69.99

Stripe and private equity firm Advent International just submitted a joint takeover offer for PayPal ($PYPL) at $60.50 per share, valuing the company at more than $53 billion - a roughly 28% premium to Tuesday's close. What do you think PayPal is really worth? Cast your vote and explain your reasoning in the comments.

What should PayPal ($PYPL) be worth in a takeover deal?

Current Price	$11.29
Prev Close	$11.02
Open	$11.11
Dividend Yield	0.00%
50-Day Moving Average	$10.40
Beta	0.00
Avg. Volume	227,418.32
PE Ratio	-535.07

52-Week High	$16.94
52-Week Low	$6.28
Market Capitalization	$3.84B
EPS (Annual)	-$0.0211
Price to Book	9.21
Revenue Per Employee	$679,591.93

Feed

News

Sentiment

Earnings

Fundamentals

Info

TLXTelix Pharmaceuticals Limited American Depositary Shares

Latest TLX News